Filtros de búsqueda

Lista de obras de

A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme

artículo científico publicado en 2019

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells

artículo científico publicado en 2016

A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses

artículo científico publicado en 2006

A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

artículo científico publicado en 2018

A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro

artículo científico publicado en 2010

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

scientific article published on 20 January 2020

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains

artículo científico publicado en 2014

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

scientific article published on 31 August 2016

An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

artículo científico publicado en 2014

An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120

artículo científico publicado en 2004

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates

artículo científico publicado en 2005

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

artículo científico publicado en 2011

Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins

artículo científico publicado en 2010

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

artículo científico publicado en 2010

Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds

artículo científico publicado en 2016

Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved

artículo científico publicado en 2014

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

artículo científico publicado en 2017

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

artículo científico publicado en 2016

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

artículo científico publicado en 2012

Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development

artículo científico publicado en 2017

Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion

artículo científico publicado en 2012

Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein

artículo científico publicado en 2005

Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1

artículo científico publicado en 2013

Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1

artículo científico publicado en 2015

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

artículo científico publicado en 2019

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance

artículo científico publicado en 2009

B cell responses to HIV-1 infection and vaccination: pathways to preventing infection

artículo científico publicado en 2010

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.

artículo científico publicado en 2017

Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies

artículo científico publicado en 2016

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

artículo científico publicado en 2011

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

artículo científico publicado en 2014

Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity

artículo científico publicado en 2014

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

artículo científico publicado en 2005

Centralized HIV-1 envelope immunogens and neutralizing antibodies

artículo científico publicado en 2007

Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity

artículo científico publicado en 2004

Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry

artículo científico publicado en 2011

Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins

artículo científico publicado en 2013

Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines

artículo científico publicado en 2013

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

artículo científico publicado en 2013

Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge

artículo científico publicado en 2017

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

artículo científico publicado en 2016

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

artículo científico publicado en 2015

Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140

artículo científico publicado en 2015

Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.

artículo científico publicado en 2005

Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein

artículo científico publicado en 2008

Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

artículo científico publicado en 2015

Comparison of multiple vaccine vectors in a single heterologous prime-boost trial

artículo científico publicado en 2008

Computational analysis of antibody dynamics identifies recent HIV-1 infection

artículo científico publicado en 2017

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

artículo científico publicado en 2014

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

scientific article published on 02 December 2019

Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies

Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies

artículo científico publicado en 2011

Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins

artículo científico publicado en 2009

Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen

artículo científico publicado en 2006

Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region

artículo científico publicado el 14 de noviembre de 2010

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

artículo científico publicado en 2002

Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.

artículo científico publicado en 2006

Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120.

artículo científico publicado en 2017

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production

artículo científico publicado en 2010

Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation

artículo científico publicado en 2011

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

artículo científico publicado en 2015

Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape

artículo científico publicado en 2012

Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells

artículo científico publicado en 2011

Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies

artículo científico publicado en 2011

Envelope glycoprotein binding to the integrin α4β7 is not a general property of most HIV-1 strains

artículo científico publicado en 2014

Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

artículo científico publicado en 2016

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus

artículo científico publicado en 2016

Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette-Guérin Vaccination to Improve Antiviral Antibody Responses

artículo científico publicado en 2020

Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma

artículo científico publicado en 2005

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

artículo científico publicado en 2014

Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001

artículo científico publicado en 2016

Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting

artículo científico publicado en 2004

Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa

artículo científico publicado en 2016

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.

artículo científico publicado en 2018

Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis

artículo científico publicado en 2006

Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility

artículo científico publicado en 2008

Glycosylation site-specific analysis of clade C HIV-1 envelope proteins

artículo científico publicado en 2009

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination

artículo científico publicado en 2011

HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies

artículo científico publicado en 2017

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees

artículo científico publicado en 2018

HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

artículo científico publicado en 2016

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design

artículo científico publicado en 2012

HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria

artículo científico publicado en 2014

HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages

artículo científico publicado en 2012

HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence

artículo científico publicado en 2015

HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis

artículo científico publicado en 2018

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities

artículo científico publicado en 2014

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities

artículo científico publicado en 2014

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

artículo científico publicado en 2014

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

artículo científico publicado en 2009

High throughput functional analysis of HIV-1 env genes without cloning

artículo científico publicado en 2007

High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies

artículo científico publicado en 2009

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

artículo científico publicado en 2015

Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection

artículo científico publicado en 2007

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements

artículo científico publicado en 2014

IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria

artículo científico publicado en 2014

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies

artículo científico publicado en 2013

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

artículo científico publicado en 2016

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

artículo científico publicado en 2012

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques

artículo científico publicado en 2016

Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.

artículo científico publicado en 2015

Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates

artículo científico publicado en 2018

Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins

artículo científico publicado en 2004

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

artículo científico publicado en 2014

Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF

scientific article published on 01 May 2002

Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses

artículo científico publicado en 2013

Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector

article

Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41

artículo científico publicado en 2011

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

artículo científico publicado en 2014

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

artículo científico publicado en 2013

Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

artículo científico publicado en 2016

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

artículo científico publicado en 2008

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

artículo científico publicado en 2011

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

artículo científico publicado en 2017

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

scientific article published on April 2016

Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery

artículo científico publicado en 2016

Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine

artículo científico publicado en 2018

Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes

artículo científico publicado en 2018

Is developing an HIV-1 vaccine possible?

artículo científico publicado el 1 de septiembre de 2010

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

artículo científico publicado en 2012

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting

artículo científico publicado en 2011

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual

artículo científico publicado en 2011

Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage

artículo científico publicado en 2015

Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys

artículo científico publicado en 2013

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

artículo científico publicado en 2015

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

artículo científico publicado en 2015

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

artículo científico publicado en 2016

Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine Candidate

artículo científico publicado en 2011

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

artículo científico publicado en 2017

Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect

artículo científico publicado en 2017

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

artículo científico publicado en 2010

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk

artículo científico publicado en 2013

Murine CD7 shares antigenic cross-reactivity with HSP-60.

artículo científico publicado en 2008

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection

artículo científico publicado en 2016

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

scientific article published on 17 September 2019

Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge

artículo científico publicado en 2013

Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens

artículo científico publicado en 2010

Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain

artículo científico publicado en 2016

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

artículo científico publicado en 2018

Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials

artículo científico publicado en 2013

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

artículo científico publicado en 2017

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection

artículo científico publicado en 2009

Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

artículo científico publicado en 2017

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion

artículo científico publicado en 2014

Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C.

artículo científico publicado en 2013

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

artículo científico publicado en 2012

Progress in HIV-1 vaccine development.

artículo científico publicado en 2014

Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys

artículo científico publicado en 2015

Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors.

artículo científico publicado en 2013

Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center

artículo científico publicado en 2021

Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites

artículo científico publicado en 2007

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation

artículo científico publicado en 2014

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

artículo científico publicado en 2009

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

artículo científico publicado en 2015

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies

scientific article published in Nature Communications

Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions

artículo científico publicado en 2009

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.

artículo científico publicado en 2017

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

artículo científico publicado en 2015

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

artículo científico publicado en 2015

Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee

artículo científico publicado en 2015

Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk

artículo científico publicado en 2013

The role of weather conditions in COVID-19 transmission: A study of a global panel of 1236 regions

artículo científico publicado en 2021

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

artículo científico publicado en 2016

Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques

scientific article published on 03 January 2014

Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design

artículo científico publicado en 2012

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

artículo científico publicado en 2015

Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge

artículo científico publicado en 2007

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

artículo científico publicado en 2017

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

artículo científico publicado en 2013

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

artículo científico publicado en 2014

Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide

artículo científico publicado en 2014

Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

artículo científico publicado en 2014

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

artículo científico publicado en 2013

Viral receptor-binding site antibodies with diverse germline origins

artículo científico publicado en 2015

epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals

artículo científico publicado en 2011